Marksans Pharma - MARKSANS, 524404 corporate action history

Marksans Pharma Ltd.

NSE: MARKSANS | BSE: 524404

Strong Performer, Getting Expensive

In 1 Starfolio Basket

Download real time

216.17 -1.25 (-0.57%)

39.46% Gain from 52W Low

1.1M

NSE+BSE Volume

NSE 21 May, 2026 3:31 PM (IST)

Board Meeting

The next board meeting for Marksans Pharma is on 26 May 2026 for the purpose of Audited Results & Final Dividend See details

Marksans Pharma Bonus history

Marksans Pharma has not announced any bonus since Jan 1, 2000.

See all forthcoming Bonus and Splits

Split history for Marksans Pharma

Marksans Pharma has split the face value 1 time since March 11, 2008. Marksans Pharma had last split the face value of its shares from ₹10 to ₹1 in 2008.The share has been quoting on an ex-split basis from March 11, 2008.

Ex-Date	Old FV	New FV	Record Date
11 Mar 2008	10	1	-

See all forthcoming Bonus and split

Dividend history for Marksans Pharma

Marksans Pharma has declared 12 dividends since Sept. 18, 2014.

In the past 12 months, Marksans Pharma has declared an equity dividend amounting to ₹0.80 per share.

At the current share price of ₹216.1700, Marksans Pharma's dividend yield is 0.37%.

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
01 Aug 2025	0.800	FINAL	01 Aug 2025	Equity Share
17 Sep 2024	0.600	FINAL	17 Sep 2024	Equity Share
07 Jun 2023	0.500	FINAL	07 Jun 2023	Equity Share
19 Aug 2022	0.250	FINAL	-	Equity Share
15 Sep 2021	0.250	FINAL	-	Equity Share
22 Sep 2020	0.100	FINAL	-	Equity Share
19 Sep 2019	0.050	FINAL	-	Equity Share
19 Sep 2018	0.050	FINAL	-	Equity Share
19 Sep 2017	0.050	FINAL	-	Equity Share
22 Sep 2016	0.120	FINAL	-	Equity Share
23 Sep 2015	0.120	FINAL	-	Equity Share
18 Sep 2014	0.100	FINAL	-	Equity Share

See all forthcoming dividends Check out stocks with top dividend.

Board Meetings - Marksans Pharma

The next board meeting for Marksans Pharma is on 26 May 2026 for the purpose of Audited Results & Final Dividend

Ex-Date	Purpose	Notes
26 May 2026	Audited Results & Final Dividend	-
05 Feb 2026	Quarterly Results	-
13 Nov 2025	Quarterly Results	-
12 Aug 2025	Quarterly Results	-
19 May 2025	Audited Results & Final Dividend	-
11 Feb 2025	Quarterly Results	-
12 Nov 2024	Quarterly Results	-
13 Aug 2024	Quarterly Results	-
30 May 2024	Audited Results & Final Dividend	-
13 Feb 2024	Quarterly Results	-

See all Board Meetings for Marksans Pharma

Marksans Pharma Rights history

Marksans Pharma has not issued any rights since Jan 1, 2000.

See all Rights History for Marksans Pharma

Is Marksans Pharma Ltd. worth buying?

1444 Votes:

Buy 80.75%

Sell 10.04%

Hold 9.21%